SERMONIX PHARMACEUTICALS, INC.

Profile

Company Names

SERMONIX PHARMACEUTICALS, INC.
SERMONIX PHARMACEUTICALS, LLC

Addresses

3000 E. MAIN ST, COLUMBUS, OH 43209

99 NORTH BRICE ROAD, SUITE 120, COLUMBUS, OH 43213

Phone Numbers

(614) 864-4919
(614) 582-6849

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2014

State Incorporated:

OHIO

Total Amount Raised:

$42,795,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2021-11-12 
$40,225,000.00 
$40,225,000.00 
$0.00 
Equity 
2
2016-07-05 
$1,550,000.00 
$2,500,000.00 
$950,000.00 
Equity 
1
2015-09-28 
$1,020,000.00 
$3,000,000.00 
$1,980,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ELIZABETH 
 
ATTIAS 
EXECUTIVE OFFICER
SERMONIX PHARMACEUTICALS, INC.
RICHARD 
 
DE SCHUTTER 
DIRECTOR
SERMONIX PHARMACEUTICALS, INC.
MICHAEL 
 
FRIEDMAN 
DIRECTOR
OCEAN TOMO INTELLECTUAL PROPERTY FUN LLC   |  MANNKIND CORP   |  IGNITE FARM FUND I, L.P.   |  MAJOR LEAGUE FANTASY, INC.   |  PARK AVENUE PLAZA LLC   |  EVINE LIVE INC.   |  IMEDIA BRANDS, INC.   |  SERMONIX PHARMACEUTICALS, INC.   |  CYTOVIA HOLDINGS, INC.
ELIZABETH 
 
GARNER 
DIRECTOR
AGILE THERAPEUTICS INC   |  SERMONIX PHARMACEUTICALS, INC.
SIMON 
 
JENKINS 
EXECUTIVE OFFICER
SERMONIX PHARMACEUTICALS, INC.   |  MARKETFUEL INC.
BARRY 
 
KOMM 
EXECUTIVE OFFICER
SERMONIX PHARMACEUTICALS, INC.
THOMAS 
 
PFISTERER 
DIRECTOR
IMVAX, INC.   |  SERMONIX PHARMACEUTICALS, INC.
PAUL 
 
PLOURDE 
EXECUTIVE OFFICER
SERMONIX PHARMACEUTICALS, INC.
DAVID 
 
PORTMAN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
SERMONIX PHARMACEUTICALS, LLC   |  SERMONIX PHARMACEUTICALS, INC.
MIRIAM 
 
PORTMAN 
EXECUTIVE OFFICER, PROMOTER, DIRECTOR
SERMONIX PHARMACEUTICALS, LLC   |  SERMONIX PHARMACEUTICALS, INC.
PATRICK 
 
WIESEL 
DIRECTOR
SERMONIX PHARMACEUTICALS, LLC
ANTHONY 
 
WILD 
EXECUTIVE OFFICER, DIRECTOR
INNOCOLL HOLDINGS, INC.   |  SLATE PHARMACEUTICALS, INC.   |  SPROUT PHARMACEUTICALS, INC.   |  SERMONIX PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-11-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-12 
2016-07-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-05 
2015-10-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2015-09-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LIFESCI CAPITAL
168404